1 y identified lysosomal pepstatin-insensitive acid protease.

2 he cDNA of human procathepsin L, a lysosomal acid protease.

3 ta indicate that GPR is an atypical aspartic acid protease.

4 ion, and the activation of cysteine aspartic acid proteases.

5  over the physiologically important aspartic acid proteases.

6 c residues and propeptide lysine of aspartic acid proteases.

7 to explore the optimal zymogram of exogenous acid protease (ACP), neutral protease (NEP), alkaline pr

8 ction in the expression of cathepsin D or in acid protease activity.

9 t binds to a specific pocket of the aspartic acid protease, beta-secretase (BACE-1).

10                                          The acid protease cathepsin D generated fragments of 31-33.5

11 ling process in the presence of barbel crude acid protease extract.

12 lyses of the uxs1Delta mutant identify three acid protease genes, notably PEP401, that are differenti

13                                           An acid protease in the anther extract converted the inacti

14 opic agent chloroquine or with inhibitors of acid proteases inhibits processing and presentation of t

15 or but not inhibitors of cysteine proteases, acid proteases, metalloproteases, or aminopeptidases abo

16 some, lysosomal cysteine proteases, aspartic acid proteases, or metalloproteases.

17                                    While the acid protease pepsin has been the enzyme of choice for H

18 roximately 7.5 mM) of the mammalian aspartic acid protease pepsin.

19 we have cloned and characterized a 188-amino acid, protease-resistant, carboxy-terminal fragment (C17

20 equires the CTD and residues within an amino acid protease-sensitive segment that joins the CTD to th

21 isive role for a family of cysteine aspartic acid proteases, termed caspases, as mediators of neurona